Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +20.21%
#2 B3 (Base) B3 (Base) +8.53%
#3 Fake World Assets Fake World Assets +8.14%
#4 Tornado Cash Tornado Cash +6.81%
#5 Geodnet Geodnet +6.39%
#6 OriginTrail OriginTrail +6.25%
#7 Audiera Audiera +5.37%
#8 Storj Storj +5.26%
#9 Pons Pons +5.16%
#10 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +5.02%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Formosa Pharmaceuticals, Inc. Formosa Pharmaceuticals, Inc.

Formosa Pharmaceuticals, Inc.

6838
Peringkat dalam Saham #20880
Formosa Pharmaceuticals, Inc., a biopharmaceutical firm situated in Taipei... Formosa Pharmaceuticals, Inc., a biopharmaceutical firm situated in Taipei City, Taiwan, is actively engaged in both late-preclinical and early clinical development stages. Its core focus lies in pioneering therapeutic candidates across ophthalmology, oncology, and anti-infective domains. Among its key investigational assets is APP13007, an ophthalmic nanosuspension, currently progressing through Phase III trials for managing post-surgical discomfort and inflammation of the eye. The company's portfolio also encompasses TSY-0110, designed as an antibody-drug conjugate, and TSY-0210, an antibiotic targeting resilient drug-resistant infections. Further compounds under development include APP13002, a topical antibiotic intended for ocular infections like blepharitis, and MPT0E028, a novel pan-histone deacetylase inhibitor being explored for solid malignancies such as hepatomas and colorectal cancer, in addition to lung fibrosis. Additionally, Formosa Pharmaceuticals maintains a collaborative partnership with Eyenovia, Inc., dedicated to advancing innovative ophthalmic treatments. Established in 2010, the company is headquartered in Taiwan's capital.
Harga Saham
$0.79338575
Terakhir disinkronkan: 2026-07-28
Kapitalisasi Pasar
$119.78M
Perubahan (1 hari)
2.67%
Perubahan (1 tahun)
-27.61%
Negara
TW
Perdagangan Formosa Pharmaceuticals, Inc. (6838)

Kategori

Healthcare
Riwayat dividen untuk Formosa Pharmaceuticals, Inc. (6838)
Saham Formosa Pharmaceuticals, Inc. (simbol: 6838) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Formosa Pharmaceuticals, Inc. (6838) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH